How we help patients

Volv Global Case Studies

We’ve helped many of the top pharma companies with tailored, data-driven insights on disease phenomenology to support getting patients personalised treatment faster. Find out how.

Black and white portrait of a woman with straight dark hair, wearing a textured knitted sweater and facing the camera with a calm expression.
All
Case Studies

MASH/NASH: Why Therapeutic Breakthroughs Demand a New Era of Patient Identification

Bridging gaps across the CLL care pathway – Part 2: Knowing When To Treat

Bridging gaps across the CLL care pathway – Part 1: From Signal to Stratification

PCMG AI Symposium 2025: Cutting Through the Hype – Real Value vs. Overpromised Innovation

Beyond the Hype: Volv Global CEO Christopher Rudolf at Frontiers Health 2025

Cracking the Multiple Myeloma Code: Why Systemic Change is Needed to Match Therapeutic Breakthroughs

Where Technology Meets Human: A Call to Unite Clinical Expertise and Real‑World Patient Voices

Unlocking the Future of Type 1 Diabetes Care: Why Earlier Diagnosis Must Match Innovation in Treatment

News Article: AI in healthcare